Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice.

Le Roy T, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A, Perlemuter G, Cassard-Doulcier AM, Gérard P.

Gut. 2013 Dec;62(12):1787-94. doi: 10.1136/gutjnl-2012-303816. Epub 2012 Nov 29.

PMID:
23197411
2.

Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.

Yin X, Peng J, Zhao L, Yu Y, Zhang X, Liu P, Feng Q, Hu Y, Pang X.

Syst Appl Microbiol. 2013 May;36(3):188-96. doi: 10.1016/j.syapm.2012.12.009. Epub 2013 Mar 1.

PMID:
23453736
3.

Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.

Porras D, Nistal E, Martínez-Flórez S, Pisonero-Vaquero S, Olcoz JL, Jover R, González-Gallego J, García-Mediavilla MV, Sánchez-Campos S.

Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.

PMID:
27890642
4.

Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.

Malloy VL, Perrone CE, Mattocks DA, Ables GP, Caliendo NS, Orentreich DS, Orentreich N.

Metabolism. 2013 Nov;62(11):1651-61. doi: 10.1016/j.metabol.2013.06.012. Epub 2013 Aug 5.

PMID:
23928105
5.

Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine.

de Wit N, Derrien M, Bosch-Vermeulen H, Oosterink E, Keshtkar S, Duval C, de Vogel-van den Bosch J, Kleerebezem M, Müller M, van der Meer R.

Am J Physiol Gastrointest Liver Physiol. 2012 Sep 1;303(5):G589-99. doi: 10.1152/ajpgi.00488.2011. Epub 2012 Jun 14.

6.

Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota.

Serino M, Luche E, Gres S, Baylac A, Bergé M, Cenac C, Waget A, Klopp P, Iacovoni J, Klopp C, Mariette J, Bouchez O, Lluch J, Ouarné F, Monsan P, Valet P, Roques C, Amar J, Bouloumié A, Théodorou V, Burcelin R.

Gut. 2012 Apr;61(4):543-53. doi: 10.1136/gutjnl-2011-301012. Epub 2011 Nov 22.

7.

Dysbiosis contributes to fibrogenesis in the course of chronic liver injury in mice.

De Minicis S, Rychlicki C, Agostinelli L, Saccomanno S, Candelaresi C, Trozzi L, Mingarelli E, Facinelli B, Magi G, Palmieri C, Marzioni M, Benedetti A, Svegliati-Baroni G.

Hepatology. 2014 May;59(5):1738-49. doi: 10.1002/hep.26695. Epub 2014 Feb 25.

PMID:
23959503
8.

A novel murine model for non-alcoholic steatohepatitis developed by combination of a high-fat diet and oxidized low-density lipoprotein.

Yimin, Furumaki H, Matsuoka S, Sakurai T, Kohanawa M, Zhao S, Kuge Y, Tamaki N, Chiba H.

Lab Invest. 2012 Feb;92(2):265-81. doi: 10.1038/labinvest.2011.159. Epub 2011 Nov 7.

9.

Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.

Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R.

Obesity (Silver Spring). 2010 Apr;18(4):780-7. doi: 10.1038/oby.2009.301. Epub 2009 Oct 1.

10.

Non-alcoholic steatohepatitis: a microbiota-driven disease.

Moschen AR, Kaser S, Tilg H.

Trends Endocrinol Metab. 2013 Nov;24(11):537-45. doi: 10.1016/j.tem.2013.05.009. Epub 2013 Jul 1. Review.

PMID:
23827477
11.

Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease.

Kim EH, Bae JS, Hahm KB, Cha JY.

Biochem Pharmacol. 2012 Nov 15;84(10):1359-65. doi: 10.1016/j.bcp.2012.08.029. Epub 2012 Sep 6.

PMID:
22981383
12.

Obesity and NAFLD: the role of bacteria and microbiota.

Duseja A, Chawla YK.

Clin Liver Dis. 2014 Feb;18(1):59-71. doi: 10.1016/j.cld.2013.09.002. Epub 2013 Oct 24. Review.

PMID:
24274865
13.

Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.

Murphy EF, Cotter PD, Hogan A, O'Sullivan O, Joyce A, Fouhy F, Clarke SF, Marques TM, O'Toole PW, Stanton C, Quigley EM, Daly C, Ross PR, O'Doherty RM, Shanahan F.

Gut. 2013 Feb;62(2):220-6. doi: 10.1136/gutjnl-2011-300705. Epub 2012 Feb 16. Erratum in: Gut. 2013 Feb;62(2):226.

PMID:
22345653
14.

N-3 long-chain polyunsaturated fatty acid supplementation significantly reduces liver oxidative stress in high fat induced steatosis.

Valenzuela R, Espinosa A, González-Mañán D, D'Espessailles A, Fernández V, Videla LA, Tapia G.

PLoS One. 2012;7(10):e46400. doi: 10.1371/journal.pone.0046400. Epub 2012 Oct 17.

15.

Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice.

Cho SJ, Jung UJ, Choi MS.

Br J Nutr. 2012 Dec 28;108(12):2166-75. doi: 10.1017/S0007114512000347. Epub 2012 Mar 14.

PMID:
22414733
16.

Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.

Pathil A, Mueller J, Warth A, Chamulitrat W, Stremmel W.

Hepatology. 2012 May;55(5):1369-78. doi: 10.1002/hep.25531. Epub 2012 Mar 18.

PMID:
22183915
17.

Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity.

Gauffin Cano P, Santacruz A, Moya Á, Sanz Y.

PLoS One. 2012;7(7):e41079. doi: 10.1371/journal.pone.0041079. Epub 2012 Jul 26.

18.

The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease.

Kim MH, Kang KS, Lee YS.

Br J Nutr. 2010 Nov;104(9):1333-42. doi: 10.1017/S0007114510002266. Epub 2010 Aug 6.

PMID:
20687969
19.

Clostridium ramosum promotes high-fat diet-induced obesity in gnotobiotic mouse models.

Woting A, Pfeiffer N, Loh G, Klaus S, Blaut M.

MBio. 2014 Sep 30;5(5):e01530-14. doi: 10.1128/mBio.01530-14.

20.

Long-term combination therapy of ezetimibe and acarbose for non-alcoholic fatty liver disease.

Nozaki Y, Fujita K, Yoneda M, Wada K, Shinohara Y, Takahashi H, Kirikoshi H, Inamori M, Kubota K, Saito S, Mizoue T, Masaki N, Nagashima Y, Terauchi Y, Nakajima A.

J Hepatol. 2009 Sep;51(3):548-56. doi: 10.1016/j.jhep.2009.05.017. Epub 2009 Jun 6.

PMID:
19596472

Supplemental Content

Support Center